- Home
- NUVB vs SLQT Comparison
NUVB vs SLQT Comparison
Compare NUVB & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUVB | SLQT |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 281.6M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NUVB | SLQT |
|---|---|---|
| Price | $9.41 | $1.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $10.63 | $3.88 |
| AVG Volume (30 Days) | ★ 6.1M | 921.8K |
| Earning Date | 11-03-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $26,748,000.00 | ★ $1,563,142,000.00 |
| Revenue This Year | $609.55 | $13.00 |
| Revenue Next Year | $197.91 | $7.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1137.19 | 13.16 |
| 52 Week Low | $1.54 | $1.33 |
| 52 Week High | $9.75 | $6.86 |
Technical Indicators
Market Signals| Indicator | NUVB | SLQT |
|---|---|---|
| Relative Strength Index (RSI) | 69.97 | 42.17 |
| Support Level | $9.06 | $1.33 |
| Resistance Level | $9.75 | $1.46 |
| Average True Range (ATR) | 0.48 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 82.31 | 19.22 |
Price Performance
Historical ComparisonAbout NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.